ChartMill assigns a Buy % Consensus number of 76% to APEN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-01-23 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2023-01-04 | Stifel | Downgrade | Buy -> Hold |
| 2022-11-30 | Lake Street | Downgrade | Buy -> Hold |
| 2022-05-04 | Stephens & Co. | Maintains | Overweight |
| 2022-02-23 | Stifel | Maintains | Buy |
| 2021-12-15 | Cowen & Co. | Initiate | Outperform |
| 2021-12-09 | Stifel | Initiate | Buy |
| 2021-09-09 | Stephens & Co. | Initiate | Overweight |
| 2021-06-14 | Piper Sandler | Maintains | Overweight |
| 2021-05-17 | Lake Street | Initiate | Buy |
11 analysts have analysed APEN and the average price target is 10.2 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.
The consensus rating for APOLLO ENDOSURGERY INC (APEN) is 76.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering APOLLO ENDOSURGERY INC (APEN) is 11.